Business article - March 9, 2021
Q&A: Renée Aguiar-Lucander, CEO, Calliditas Therapeutics
Calliditas Therapeutics is about to bring its treatment for IgA nephropathy to the market – addressing a significant unmet medical need. Calliditas, formed in 2004, is a Swedish clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases. The company’s lead product […]
Business article - March 8, 2021
The gender gap in life science start-ups
Hadean Ventures, a Nordic-based European life science VC firm, is deeply involved in both the investment management industry and the life sciences start-up community. Operating at this intersection, it soon became clear to Ingrid Teigland Akay, Founder and Managing Partner, that both industries have specific challenges related to diversity in leadership teams. To change this, […]
Business article - February 16, 2021
Medtech – A hotter investment sector than ever, shows new analysis
The communications consultancy company Paues Åberg has analyzed the investment interest of the Swedish life science sector and found that investments in the field of medtech has increased by 235% during the last two years. “A good approach to understand the latest trends within investor relations is to analyze raised capital in different industries and […]
Business article - February 1, 2021
Hey there: Hanna Sjöström, CEO, GPX Medical
GPX Medical is building on a historic Swedish legacy of medical technology innovation and the company’s mission is to revolutionize the care of infants born preterm. GPX Medical was founded in Lund, Sweden, in 2016 and is developing NEOLA, a lung analyzer for continuous monitoring of the lungs of preterm-born infants using a technology that […]
Business article - December 8, 2020
The Novo Nordisk Foundation establishes BioInnovation Institute as an independent foundation
The Novo Nordisk Foundation has announced that BioInnovation Institute (BII), a Novo Nordisk Foundation initiative, has been established as an independent foundation in recognition of its success incubating and accelerating world-class life science research. BII was established in December 2017 by the Novo Nordisk Foundation with the purpose to advance research, innovation and entrepreneurship within […]
Business article - November 20, 2020
A new Swedish cell and gene therapy company has been launched
Elicera Therapeutics has announced that it has completed its first share issue and secured SEK 13.2 million in financing. The company is based on research by professor Magnus Essand’s research group at Uppsala University and will focus on CAR T-cells and oncolytic viruses. “In the CAR T-cell space, we have two drug candidates under development […]
